Human medicines European public assessment report (EPAR): Sitagliptin Accord, sitagliptin, Date of authorisation: 25/04/2022, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Lojuxta, lomitapide, Date of authorisation: 31/07/2013, Revision: 20, Status: Authorised
Agenda of the CHMP meeting 27-30 January 2025
Annex to 27-30 January 2025 CHMP Agenda
EMA celebrates 30 years of progress in science and medicines in the European Union
Human medicines European public assessment report (EPAR): Izba, travoprost, Date of authorisation: 20/02/2014, Revision: 8, Status: Authorised
Pregabalin Accord : EPAR - Risk management plan
Medicinal products for human use: Monthly figures - December 2024
Veterinary medicinal products for zootechnical purposes - Scientific guideline
Training on human variations web-based electronic application form (eAF) functionalities for non-CAPs variations, Online, European Medicines Agency, Amsterdam, the Netherlands, from 27 February 2025, 10:30 (CET) to 27 February 2025, 12:30 (CET)